Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.
Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):363-70.PMID: 8673545 [PubMed - indexed for MEDLINE]Related articles